Khoo Bernard, Akker Scott A, Chew Shern L
Department of Endocrinology, St Bartholomew's Hospital, London EC1A 7BE, UK.
Trends Biotechnol. 2003 Aug;21(8):328-30. doi: 10.1016/S0167-7799(03)00168-9.
Spinal muscular atrophy is a neurodegenerative disease caused by mutations of the SMN1 gene. The homologous SMN2 gene is unable to complement SMN1 because of a crucial mutation in an exonic splicing enhancer, leading to alternative splicing and exclusion of exon 7. Two recent papers show that the defect in splicing of exon 7 of SMN2 is specifically corrected by small synthetic effectors. These new and specific approaches have potential in the treatment of diseases caused by defective splicing.
脊髓性肌萎缩症是一种由SMN1基因突变引起的神经退行性疾病。同源的SMN2基因由于外显子剪接增强子中的关键突变而无法补充SMN1,导致外显子7的可变剪接和排除。最近的两篇论文表明,SMN2外显子7剪接缺陷可被小的合成效应物特异性纠正。这些新的特异性方法在治疗由剪接缺陷引起的疾病方面具有潜力。